European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. / Kos-Kudła, Beata; Castaño, Justo P.; Denecke, Timm; Grande, Enrique; Kjaer, Andreas; Koumarianou, Anna; de Mestier, Louis; Partelli, Stefano; Perren, Aurel; Stättner, Stefan; Valle, Juan W.; Fazio, Nicola.
In: Journal of Neuroendocrinology, Vol. 35, No. 12, e13343, 2023.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
AU - Kos-Kudła, Beata
AU - Castaño, Justo P.
AU - Denecke, Timm
AU - Grande, Enrique
AU - Kjaer, Andreas
AU - Koumarianou, Anna
AU - de Mestier, Louis
AU - Partelli, Stefano
AU - Perren, Aurel
AU - Stättner, Stefan
AU - Valle, Juan W.
AU - Fazio, Nicola
N1 - Publisher Copyright: © 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.
PY - 2023
Y1 - 2023
N2 - This ENETS guidance paper for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET) has been developed by a multidisciplinary working group, and provides up-to-date and practical advice on the management of these tumours. Using the extensive experience of centres treating patients with NF-Pan-NEN, the authors of this guidance paper discuss 10 troublesome questions in everyday clinical practice. Our many years of experience in this field are still being verified in the light of the results of new clinical, which set new ways of proceeding in NEN. The treatment of NF-Pan-NEN still requires a decision of a multidisciplinary team of specialists in the field of neuroendocrine neoplasms.
AB - This ENETS guidance paper for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET) has been developed by a multidisciplinary working group, and provides up-to-date and practical advice on the management of these tumours. Using the extensive experience of centres treating patients with NF-Pan-NEN, the authors of this guidance paper discuss 10 troublesome questions in everyday clinical practice. Our many years of experience in this field are still being verified in the light of the results of new clinical, which set new ways of proceeding in NEN. The treatment of NF-Pan-NEN still requires a decision of a multidisciplinary team of specialists in the field of neuroendocrine neoplasms.
KW - diagnostics
KW - guideline
KW - neuroendocrine tumour
KW - pancreatic nonfunctioning neuroendocrine tumour
KW - treatment
U2 - 10.1111/jne.13343
DO - 10.1111/jne.13343
M3 - Journal article
C2 - 37877341
AN - SCOPUS:85174564454
VL - 35
JO - Journal of Neuroendocrinology
JF - Journal of Neuroendocrinology
SN - 0953-8194
IS - 12
M1 - e13343
ER -
ID: 374315069